Latham & Watkins LLP represented Zogenix in the offering. Zogenix, Inc., a global biopharmaceutical company, has announced the pricing of its offering of US$200 million aggregate…
Latham & Watkins LLP represented Zogenix in the offering. Zogenix, Inc., a global biopharmaceutical company, has announced the pricing of its offering of US$200 million aggregate…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.